Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -670.89% | -2.01% | -154.86% | -396.41% | -113.54% |
| Total Depreciation and Amortization | 21.66% | 44.23% | -28.79% | 42.34% | -1.85% |
| Total Amortization of Deferred Charges | -0.93% | -2.30% | -5.79% | 2.53% | -26.03% |
| Total Other Non-Cash Items | -98.88% | 22.20% | -28.52% | -4.51% | -9.43% |
| Change in Net Operating Assets | -5.58% | -218.77% | 109.96% | 106.26% | 45.20% |
| Cash from Operations | -171.45% | -13.63% | -16.01% | 42.87% | -39.76% |
| Capital Expenditure | -87.00% | -20.64% | -126.69% | -91.07% | -12.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.82% | 164.75% | 257.74% | -- | -- |
| Cash from Investing | 33.44% | 92.58% | -35.07% | -1,972.28% | -293.79% |
| Total Debt Issued | -85.32% | 94.51% | -83.45% | 1,076.00% | 3,532.35% |
| Total Debt Repaid | -0.95% | -61.71% | 26.86% | -442.18% | -21.77% |
| Issuance of Common Stock | -85.04% | -100.00% | -100.00% | -100.00% | 175.06% |
| Repurchase of Common Stock | 31.58% | -730.25% | 99.86% | -48,054.81% | 97.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | -90.14% | -3.77% | 59.90% | -776.72% | 320.48% |
| Foreign Exchange rate Adjustments | 191.26% | -201.04% | 258.95% | -428.17% | -629.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.30% | 1,069.21% | 99.78% | -20,739.45% | 311.33% |